Yahoo
NasdaqGS - Delayed Quote USD

Apyx Medical Corporation (APYX)

3.0500 -0.0100 (-0.33%)
At close: September 4 at 4:00:01 PM EDT
3.1085 +0.0585 (+1.92%)
After hours: September 4 at 7:30:03 PM EDT
Trade APYX on Coinbase
Chart Range Bar
Loading chart for APYX
  • Previous Close 3.0600
  • Open 3.0600
  • Bid 2.2000 x 200
  • Ask 3.0800 x 500
  • Day's Range 3.0200 - 3.0800
  • 52 Week Range 1.7000 - 5.0800
  • Volume 60,906
  • Avg. Volume 120,909
  • Market Cap (intraday) 128.478M
  • Beta (5Y Monthly) 1.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2000
  • Earnings Date (est.) Nov 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 6.60

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

apyxmedical.com

205

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

APYX
12.86%
S&P 500 (^GSPC)
12.75%

1-Year Return

APYX
48.78%
S&P 500 (^GSPC)
18.71%

3-Year Return

APYX
32.22%
S&P 500 (^GSPC)
70.93%

5-Year Return

APYX
72.96%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 13.88M
Earnings -3.24M
Profit Margin -23.36%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
5M
10M
15M
-20.0%
-15.0%
-10.0%

Analyst Insights

View More

Analyst Price Targets

6.00
6.60 Average
3.0500 Current
8.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 7/13/2026
Analyst HC Wainwright & Co.
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 7

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -14.78%

  • Return on Assets (ttm)

    -3.71%

  • Return on Equity (ttm)

    -90.69%

  • Revenue (ttm)

    58.41M

  • Net Income Avi to Common (ttm)

    -8.63M

  • Diluted EPS (ttm)

    -0.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    27.62M

  • Total Debt/Equity (mrq)

    357.35%

  • Levered Free Cash Flow (ttm)

    -9.63M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: